Yueliang Xie
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria 4
- Nephrology top 10%
- Acute Kidney Injury Research 5
- Chronic Kidney Disease and Diabetes 4
- Transplantation top 10%
- Renal Transplantation Outcomes and Treatments 2
-
- Antibiotics Pharmacokinetics and Efficacy 6
-
- Pneumonia and Respiratory Infections 3
-
- Blood Pressure and Hypertension Studies 2
-
- Trauma, Hemostasis, Coagulopathy, Resuscitation 2
- Journals
- Frontiers in Pharmacology (6 papers)Drug Metabolism and Pharmacokinetics (1 paper)Analytical Methods (1 paper)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Yueliang Xie
22 papers receiving 346 citations
Peers
Comparison fields: 5 of 91
- Molecular Medicine 57
- Nephrology 72
- Transplantation 22
- Applied Microbiology and Biotechnology 11
- Pharmacology 67
Countries citing papers authored by Yueliang Xie
This map shows the geographic impact of Yueliang Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yueliang Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yueliang Xie more than expected).
Fields of papers citing papers by Yueliang Xie
This network shows the impact of papers produced by Yueliang Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yueliang Xie. The network helps show where Yueliang Xie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yueliang Xie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 6 | |
| 2 | 2024 | 6 | |
| 3 | 2022 | 10 | |
| 4 | 2022 | 15 | |
| 5 | 2022 | 19 | |
| 6 | 2021 | 7 | |
| 7 | 2021 | 12 | |
| 8 | 2021 | 14 | |
| 9 | 2021 | 2 | |
| 10 | 2021 | 27 | |
| 11 | 2020 | 8 | |
| 12 | 2020 | 10 | |
| 13 | 2020 | 5 | |
| 14 | 2019 | 13 | |
| 15 | 2019 | 63 | |
| 16 | 2018 | 33 | |
| 17 | 2018 | 1 | |
| 18 | 2013 | 26 | |
| 19 | 2008 | 54 | |
| 20 | RP-HPLC study of resveratrol derivative (BTM-0512) in rat plasma and tissue distribution. | 2007 | 8 |
About Yueliang Xie
Yueliang Xie is a scholar working on Nephrology, Molecular Medicine, Transplantation, Critical Care and Intensive Care Medicine and Pharmacology, having authored 22 papers that have together received 349 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Acute Kidney Injury Research (5 papers), Antibiotic Resistance in Bacteria (4 papers), Chronic Kidney Disease and Diabetes (4 papers), Pneumonia and Respiratory Infections (3 papers), Renal Transplantation Outcomes and Treatments (2 papers), Blood Pressure and Hypertension Studies (2 papers) and Trauma, Hemostasis, Coagulopathy, Resuscitation (2 papers). The work is most often cited by research in Molecular Medicine (57 citations), Nephrology (72 citations), Transplantation (22 citations), Applied Microbiology and Biotechnology (11 citations) and Pharmacology (67 citations). Yueliang Xie has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Xiao‐cong Zuo, Jianglin Wang, Siyuan Li, Yongge Sun, Yongqiang Xiong, Wenjun Yin, Wanying Yang, Yun Li, Shanru Zuo and Bikui Zhang. Their work appears in journals such as Frontiers in Pharmacology, Drug Metabolism and Pharmacokinetics, Analytical Methods, BMC Nephrology and Journal of Pharmacological Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.